 |
 |

Is Triiodothyronine Administration Beneficial in Patients Undergoing Coronary Artery Bypass Surgery?
Kenneth D. Burman, MD
JAMA. 1996;275(9):723-724.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
There have been significant advances in our understanding of thyroid pathophysiology as well as in our ability to measure thyroid-stimulating hormone (TSH), total and free triiodotriiodo- (T3), and thyroxine (T4).1 The thyroid gland normally produces approximately 90 µg of T4 and 40 µg of T3 daily; all of circulating T4 is derived from direct thyroidal secretion, whereas about 85% of T3 comes from extra thyroidal conversion of T4 to T3, with only about 15% of T3 being produced by direct thyroidal secretion. Over 99% of circulating T4 and T3 are bound to serum-binding proteins, and it is only the small unbound fraction that is biologically active. Thyroxine is mainly a prohormone, and T3 is responsible for most if not all of the biological activity attributable to thyroid hormone. In many clinical situations, including systemic illness, surgery, and
. . . [Full Text PDF of this Article]
Author Affiliations
From the Endocrinology Division, Washington Hospital Center, and the Endocrine Division, George Washington University Medical Center, Washington, DC.
Footnotes
Reprint requests to Chief, Endocrine Section, Washington Hospital Center, Washington, DC 20010 (Dr Burman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|